Pharvaris to Present Clinical Data of PHA121 for the Treatment of Hereditary Angioedema at the 2021 AAAAI Annual Meeting
- Monday, February 1, 2021, 7:13
- PR Newswire
- Add a comment
ZUG, Switzerland, Feb. 1, 2021 /PRNewswire/ — Pharvaris, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary…
About the Author
admin has written 21630 stories on this site.